Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
1.1Raman fingerprint identification
What ifWhat if a Raman spectrum serves as the sole solid-form fingerprint for routine sample identification?
Claim language“the powder XRD pattern”
A near-infrared laser excites the powder, and a spectrometer records lattice and molecular vibrational bands. The workflow compares selected band positions and intensity ratios with a reference spectrum acquired at the same temperature.
1.1Solid-state carbon fingerprint identification
What ifWhat if a solid-state carbon-13 spectrum serves as the sole solid-form fingerprint for routine sample identification?
Claim language“the powder XRD pattern”
A magic-angle-spinning probe collects a carbon-13 spectrum of the powdered citrate using cross-polarization. The workflow compares resolved citrate carbonyl and tricyclic carbon resonances with reference chemical shifts and peak multiplicities.
Section 2 · machine-generated
Variations
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
Component substitution
Capillary mounting for powder diffraction
A sealed borosilicate capillary replaces the flat powder holder in a transmission powder diffractometer. A 0.7 mm capillary contains a loose column of the citrate monohydrate and rotates about its long axis during acquisition. With the reference X-ray wavelength and a calibrated angular scale, the analyst compares the observed peak positions with the six diagnostic positions within ±0.2° 2θ.
Parameter or scale variation
Milligram scale diffraction on silicon
A zero-background silicon holder supports a 2 to 5 mg portion of the citrate monohydrate. A mask limits the beam footprint to the powder bed throughout a 5° to 28° 2θ scan. At the reference X-ray wavelength, the diffractometer samples every 0.02° 2θ and uses a counting time of 3 seconds per step to locate the six diagnostic peaks.
Combination with existing systems
Humidity cycling with in situ diffraction
A powder diffractometer fitted with a humidity-controlled chamber holds a shallow bed of the citrate monohydrate. A controller mixes dry and humidified gas and cycles the chamber through 30%, 60%, and 30% relative humidity at 25 °C, with a 2-hour hold at each setting. The instrument collects a pattern at the end of each hold and tracks the six diagnostic peak positions and the appearance of additional reflections.
Thermogravimetric measurement of hydrate water
A thermogravimetric analyzer with an evolved-gas mass spectrometer measures a portion of powder from the same sample used to collect the diagnostic diffraction pattern. The analyzer heats the portion under dry nitrogen at 2 °C per minute and records the mass trace and the water ion signal. The analyst integrates the mass loss associated with water evolution before decomposition and compares it with the calculated mass fraction for one water molecule per citrate salt formula unit.
Automated or data-driven variant
Automated matching of diagnostic diffraction peaks
Software receives a calibrated powder diffraction trace collected at the reference X-ray wavelength and subtracts a slowly varying background. It identifies local maxima with prominence at least five times the local noise estimate and matches each maximum to at most one of the six reference positions within ±0.2° 2θ. The report lists the measured positions and offsets and flags any missing peak for review.
Specific version of a part
Flat plate reflection measurement
A back-loaded powder holder presents a level specimen surface to a reflection diffractometer with monochromatic copper Kα1 radiation. A scan from 4° to 30° 2θ in 0.02° steps checks for peak centers within ±0.2° of 6.94°, 9.99°, 16.57°, 18.17°, 23.68° and 26.39°.
Rotating capillary transmission measurement
A sealed, rotating 0.5 mm glass capillary presents the powder to a transmission diffractometer with monochromatic copper Kα1 radiation. The calibrated pattern is checked for peaks at 6.94°, 9.99°, 16.57°, 18.17°, 23.68° and 26.39° 2θ, each within ±0.2°.
Section 3 · quoted from USPTO records
Other work
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
1.1the monohydrate crystalline form comprises 2θ (±0.2°) values of 6.94°, 9.99°, 16.57°, 18.17°, 23.68° and 26.39° in the powder XRD pattern.
Levosalbutamol sulphate crystalline Form III is characterized by an X-ray powder diffraction pattern having significant reflections expressed as 2 theta values at about 5.496, 6.901, 7.340, 18.660±0.2 degrees, as will be clear from Table 3.
A · US 7,579,505 B2 · ¶ 45
In a further embodiment the composition is characterized by a powder x-ray diffraction pattern having reflections at 2 theta=25.8°, 23.8°, and 23.0°.
B · US 9,120,815 B2 · ¶ 13
An empty cell means only that no passage was reproduced there.
Statements in these documents
The object of the present invention is to provide novel and stable polymorphic forms of levosalbutamol sulphate named herewith as Form I, Form II and Form III.
A · US 7,579,505 B2 · ¶ 9
The present disclosure relates to heterocyclic protein kinase inhibitors, solid state forms of the same, pharmaceutical compositions containing the same, methods of making and using these compounds and compositions to treat proliferative disease mediated by kinase activity.
B · US 9,120,815 B2 · ¶ 2
Cite aspatent.fyi, US 2026/0356815 A1, claim 1, first published 2026-11-20T07:31:16-05:00, https://patent.fyi/US20260356815/, SHA-256 0d3e7f7e9794d66190db9f4137d9d5a344fc0a230810b5a2010633c038134bb8